InvestorsHub Logo
Followers 5
Posts 1274
Boards Moderated 0
Alias Born 04/15/2019

Re: None

Monday, 05/16/2022 11:04:32 AM

Monday, May 16, 2022 11:04:32 AM

Post# of 1673
Aegis Capital Adjusts Price Target for Oramed Pharmaceuticals to $30 From $35, Maintains Buy Rating
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ORMP News